ZHUO JINCONG,METCALF BRIAN,XU MEIZHONG,HE CHUNHONG,ZHANG COLIN,QIAN DING-QUAN,BURNS DAVID M.,LI YUNLONG,YAO WENQING,Zhuo Jincong,Metcalf Brian,Xu Meizhong,He Chunhong,Zhang Colin,Qian Ding-quan,Burns David M.,Li
申请号：
SI200731739
公开号：
SI2497470T1
申请日:
2007.11.19
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention is directed to imidazo[1,2-b][1,2,4]triazines and imidazo[1,2-a]pyrimidines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
